SPOTLIGHT: Merck KGaA clears way for Bayer
Merck KGaA has agreed to sell its 21.8 percent stake in Schering to Bayer, clearing the way for Bayer's takeover. Article (WSJ sub. req.)
Deal-Making Insights for the Life Sciences Industry
Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.
